159 related articles for article (PubMed ID: 35383610)
1. Extranodal NK/T-Cell Lymphoma With Widespread Cutaneous and Subcutaneous Involvement on 18 F-FDG PET/CT.
Filizoglu N; Ozguven S; Ones T; Turoglu HT; Erdil TY
Clin Nucl Med; 2022 Oct; 47(10):e630-e631. PubMed ID: 35383610
[TBL] [Abstract][Full Text] [Related]
2. Primary Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma of Lower Limb Muscles on 18 F-FDG PET/CT.
Li C; Hu X
Clin Nucl Med; 2024 Jan; 49(1):e45-e46. PubMed ID: 37976527
[TBL] [Abstract][Full Text] [Related]
3. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
4. Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
Huang M; Wang R; Shen G; Tian R
Clin Nucl Med; 2022 Oct; 47(10):914-915. PubMed ID: 35619195
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in a Case of Esophageal Extranodal NK/T-Cell Lymphoma, Nasal Type.
Zhang J; Ji X; Dong A; Wang Y
Clin Nucl Med; 2023 May; 48(5):442-444. PubMed ID: 36727864
[TBL] [Abstract][Full Text] [Related]
7. Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.
Dong P; Wang L; Shen G; Li L
Medicine (Baltimore); 2019 Mar; 98(11):e14818. PubMed ID: 30882662
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
9. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.
Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY
Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758
[TBL] [Abstract][Full Text] [Related]
10. Dynamic evaluation of the prognostic value of
Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
[TBL] [Abstract][Full Text] [Related]
11. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
[TBL] [Abstract][Full Text] [Related]
12. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
Berk V; Yildiz R; Akdemir UO; Akyurek N; Karabacak NI; Coskun U; Benekli M
Clin Nucl Med; 2008 May; 33(5):365-6. PubMed ID: 18431160
[TBL] [Abstract][Full Text] [Related]
13. Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma Recurrence at Penile Glans Masquerading Urinary Contamination on 18 F-FDG PET/CT.
Zhang Y; Yu L; Wang R; Su M
Clin Nucl Med; 2023 Sep; 48(9):812-814. PubMed ID: 37418289
[TBL] [Abstract][Full Text] [Related]
14. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
[TBL] [Abstract][Full Text] [Related]
15. Baseline SUVmax of 18F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma.
Xia X; Wang Y; Yuan J; Sun W; Jiang J; Liu C; Zhang Q; Ma X
Medicine (Baltimore); 2020 Sep; 99(37):e22143. PubMed ID: 32925768
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
Zhang Y; Zhou J; Wang L; Li JY; Ding CY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
[No Abstract] [Full Text] [Related]
19. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma.
Ding JJ; Chen YL; Zhou SH; Zhao K
J Int Med Res; 2018 Dec; 46(12):4920-4929. PubMed ID: 30328364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
